The combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients
Authors
Keywords
Pancreatic cancer, Tumor marker, CA19-9, Prognostic factor
Journal
SURGERY TODAY
Volume 44, Issue 9, Pages 1692-1701
Publisher
Springer Nature
Online
2013-10-09
DOI
10.1007/s00595-013-0752-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Surgical results of pancreatoduodenectomy in elderly patients
- (2012) Shinichiro Yamada et al. SURGERY TODAY
- Correlation Between Radiographic Classification and Pathological Grade of Portal Vein Wall Invasion in Pancreatic Head Cancer
- (2011) Akimasa Nakao et al. ANNALS OF SURGERY
- Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
- (2011) Shojiro Hata et al. ANNALS OF SURGICAL ONCOLOGY
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- Pattern of Lymph Node Metastasis Spread in Pancreatic Cancer
- (2011) Mitsuro Kanda et al. PANCREAS
- Medical treatment of pancreatic cancer: New hopes after 10years of gemcitabine
- (2011) Isabelle Trouilloud et al. Clinics and Research in Hepatology and Gastroenterology
- Invasion of the Splenic Artery Is a Crucial Prognostic Factor in Carcinoma of the Body and Tail of the Pancreas
- (2010) Mitsuro Kanda et al. ANNALS OF SURGERY
- Nutritional predictors of postoperative outcome in pancreatic cancer
- (2010) M. Kanda et al. BRITISH JOURNAL OF SURGERY
- Epidemiology of Pancreatic Cancer: An Update
- (2010) Patrick Maisonneuve et al. DIGESTIVE DISEASES
- Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study
- (2010) Giuseppe Colucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
- (2009) M. J. Duffy et al. ANNALS OF ONCOLOGY
- Feasibility and Efficacy of Combination Therapy With Preoperative Full-Dose Gemcitabine, Concurrent Three-Dimensional Conformal Radiation, Surgery, and Postoperative Liver Perfusion Chemotherapy for T3-Pancreatic Cancer
- (2009) Hiroaki Ohigashi et al. ANNALS OF SURGERY
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
- (2009) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- A Compendium of Potential Biomarkers of Pancreatic Cancer
- (2009) H. C. Harsha et al. PLOS MEDICINE
- Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma
- (2008) Shishir K. Maithel et al. ANNALS OF SURGICAL ONCOLOGY
- Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Stefan Heinrich et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Douglas B. Evans et al. JOURNAL OF CLINICAL ONCOLOGY
- CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial
- (2008) Viviane Hess et al. LANCET ONCOLOGY
- Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma
- (2008) Shun Zhang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started